Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SUVEN PHARMACEUTICALS LTD.

NSE : SUVENPHARBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE659.1013 (+2.01 %)
PREV CLOSE () 646.10
OPEN PRICE () 652.45
BID PRICE (QTY) 658.00 (1)
OFFER PRICE (QTY) 659.10 (81)
VOLUME 2361
TODAY'S LOW / HIGH ()649.75 663.65
52 WK LOW / HIGH ()427.05 767
NSE658.6011.8 (+1.82 %)
PREV CLOSE() 646.80
OPEN PRICE () 648.00
BID PRICE (QTY) 658.60 (2)
OFFER PRICE (QTY) 658.95 (28)
VOLUME 56418
TODAY'S LOW / HIGH() 648.00 663.95
52 WK LOW / HIGH ()468.6 768
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2018

Management Info :

Annaswamy Vaidheesh - Chairman V Prasada Raju - Managing Director

Registered Office :

Address : 215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri East, Chakala Midc,
Mumbai,
Maharashtra-400093

Phone : 040 - 2354 9414 / 1142 /3311

Website : www.suvenpharm.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
01Mar Suven Pharmaceuticals shines on planni
Suven Pharmaceuticals is currently trading at Rs. 678.65, up by 47.75 po..
29Feb Scheme of Arrangement
Scheme of Arrangement Inter alia, have considered and approved a scheme..
29Feb Amalgamation
Scheme of Arrangement Inter alia, have considered and approved a scheme..
23Feb USFDA completes inspections at Suven P
US Food & Drug Administration (US FDA) has completed Pre-Approval In..
06Dec Suven Pharmaceuticals informs about di
Suven Pharmaceuticals has informed that the exchange has received the di..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit523.634326.02
Gross Profit 695.02 5793.93
Operating Profit 821.056276.3
Net Sales 2128.2713300.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8279.95 (1.78%)
M.Cap ( in Cr)
18972.05
Astrazeneca Pharma I (BSE)
 5435.00 (2.55%)
M.Cap ( in Cr)
13605.00
Abbott India (BSE)
 25856.45 (0.51%)
M.Cap ( in Cr)
54961.32
Divi's Lab (BSE)
 3965.60 (3.25%)
M.Cap ( in Cr)
105807.81
Alkem Laboratories (BSE)
 4908.80 (1.05%)
M.Cap ( in Cr)
58733.32
Shareholding Pattern
PROMOTERS 50.1%
NON-INSTITUTION 23.1%
MUTUAL FUNDS/UTI 15.26%
FI/BANKS/INSURANCE 1.57%
GOVERNMENT 0.01%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74203.31-136.13 (-0.18%)
NIFTY22539.30-31.05 (-0.14%)
Dow Jones 38460.92-42.77 (-0.11%)
Nasdaq 15712.7516.11 (0.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI